Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.3777
|
0.3887
|
0.3801
|
0.3774
|
0.3887
|
0.3776
|
|
|
17 950.35
|
149.00
|
0.37
|
0.3775
|
0.3887
|
0.37
|
0.3887
|
0.3775
|
|
|
32 599.82
|
214.00
|
0.38
|
0.3887
|
0.3631
|
0.3631
|
0.375
|
0.375
|
|
|
16 099.48
|
190.00
|
0.363
|
0.37
|
0.37
|
0.363
|
0.378
|
0.3631
|
|
|
14 287.54
|
135.00
|
0.3601
|
0.38
|
0.37
|
0.36101
|
0.38
|
0.362
|
|
|
16 963.64
|
214.00
|
0.36
|
0.37
|
0.3584
|
0.3584
|
0.3699
|
0.3691
|
|
|
23 098.24
|
270.00
|
0.36
|
0.37
|
0.377
|
0.3611
|
0.379999
|
0.3611
|
|
|
17 385.72
|
262.00
|
0.372
|
0.38
|
0.3732
|
0.363
|
0.38
|
0.372
|
|
|
26 413.45
|
267.00
|
0.37
|
0.379
|
0.379
|
0.371
|
0.39
|
0.379
|
|
|
173 708.75
|
797.00
|
0.365
|
0.38
|
0.377
|
0.3648
|
0.38
|
0.3704
|
|
|
40 312.76
|
262.00
|
Tharimmune is a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death (IMCD) for drug resistant and devastating cancers.